Literature DB >> 23340062

Patients with obstructive jaundice and biliary stricture ± mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA.

Pavan Tummala1, Satish Munigala, Mohamad A Eloubeidi, Banke Agarwal.   

Abstract

BACKGROUND: In patients with obstructive jaundice and biliary stricture, the role of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is debated for fear of missing a potentially resectable pancreatobiliary malignancy (PBM). We evaluated the prevalence of (1) PBM; (2) lesions that do not require a potentially curative cancer surgery; and (3) potentially resectable PBMs in patients with false-negative diagnosis by EUS-FNA. PATIENTS AND METHODS: This is a retrospective analysis of 342 patients who underwent EUS/EUS-FNA from 2002 to 2009 after presenting with obstructive jaundice and a biliary stricture. Of these, 170 patients had no definitive mass on computed tomography and 172 patients had definitive mass on computed tomography without evidence of unresectability. Final diagnosis was based on surgical pathology or definitive cytology and clinical follow-up of ≥ 12 months.
RESULTS: The mean age of patients (176 male) was 68.0±12.5 years. A final diagnosis of malignancy was made in only 248 patients (72.5%; 95% confidence interval, 67.7, 77.2). The overall accuracy of EUS-FNA for diagnosing malignancy was 92.4% (89.0, 94.8), with 91.5% sensitivity (87.1, 94.5) and 80.9% negative predictive value (72.0, 87.5). Among 21 patients with false-negative diagnosis, 8 had cholangiocarcinoma (2 resectable), 13 had pancreatic cancer (5 resectable). EUS-FNA provided information to potentially modify surgical management in 116 patients (33.9%; 95% confidence interval, 29.1, 39.0): 89 patients diagnosed as true negatives, 24 with distant malignant lymphadenopathy, and 3 with malignant lymphoma.
CONCLUSIONS: In above-defined patient subset, the risk of missing resectable tumors by EUS-FNA has been exaggerated because of artifactually low negative predictive value resulting from a high pretest probability of PBM. The actual miss rate for resectable PBM by EUS-FNA is rather small and was 2% in present cohort. Information from EUS-FNA can potentially modify surgical management in up to one third of patients.

Entities:  

Mesh:

Year:  2013        PMID: 23340062     DOI: 10.1097/MCG.0b013e3182745d9f

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  30 in total

Review 1.  Usefulness of endoscopic ultrasound-guided fine needle aspiration in the diagnosis of hepatic, gallbladder and biliary tract Lesions.

Authors:  Ghassan M Hammoud; Ashraf Almashhrawi; Jamal A Ibdah
Journal:  World J Gastrointest Oncol       Date:  2014-11-15

Review 2.  Benign Biliary Strictures.

Authors:  Ashley Altman; Steven M Zangan
Journal:  Semin Intervent Radiol       Date:  2016-12       Impact factor: 1.513

Review 3.  Endoscopic palliation of malignant biliary strictures.

Authors:  Sanjay M Salgado; Monica Gaidhane; Michel Kahaleh
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

4.  Absence of a Periampullary Mass on Cross-sectional Imaging Delays Diagnosis and Time to Pancreatoduodenectomy But Does Not Impair Outcome.

Authors:  Hideo Takahashi; Maitham A Moslim; Naftali Presser; Colin O'Rourke; Jane Wey; Sricharan Chalikonda; Matthew R Walsh; Gareth Morris-Stiff
Journal:  J Gastrointest Surg       Date:  2016-03-16       Impact factor: 3.452

Review 5.  Systematic review and meta-analysis of percutaneous transluminal forceps biopsy for diagnosing malignant biliary strictures.

Authors:  Tae Yeon Jeon; Moon Hyung Choi; Seung Bae Yoon; Sung-Hoon Moon; Jae Seung Soh
Journal:  Eur Radiol       Date:  2021-09-18       Impact factor: 5.315

Review 6.  Cell-block procedure in endoscopic ultrasound-guided-fine-needle-aspiration of gastrointestinal solid neoplastic lesions.

Authors:  Antonio Ieni; Valeria Barresi; Paolo Todaro; Rosario Alberto Caruso; Giovanni Tuccari
Journal:  World J Gastrointest Endosc       Date:  2015-08-25

7.  Surgically proved visually isoattenuating pancreatic adenocarcinoma undetected in both dynamic CT and MRI. Was blind pancreaticoduodenectomy justified?

Authors:  Konstantinos Blouhos; Konstantinos A Boulas; Dimitrios G Tselios; Stavroula P Katsaouni; Basiliki Mauroeidi; Anestis Hatzigeorgiadis
Journal:  Int J Surg Case Rep       Date:  2013-02-24

Review 8.  Evaluation of indeterminate biliary strictures.

Authors:  Christopher L Bowlus; Kristin A Olson; M Eric Gershwin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-11-03       Impact factor: 46.802

9.  Impact of peroral cholangioscopy on the management of indeterminate biliary conditions: a multicentre prospective trial.

Authors:  Frederic Prat; Sarah Leblanc; Frantz Foissac; Thierry Ponchon; René Laugier; Philippe Bichard; Frédérique Maire; Dimitri Coumaros; Antoine Charachon; Bruno Vedrenne; Isabelle Boytchev; Stanislas Chaussade; Nadira Kaddour; Arthur Laquière; Sèbastien Gaujoux
Journal:  Frontline Gastroenterol       Date:  2018-11-27

10.  How SpyGlass™ May Impact Endoscopic Retrograde Cholangiopancreatography Practice and Patient Management.

Authors:  Pedro Pereira; Filipe Vilas-Boas; Armando Peixoto; Patrícia Andrade; Joanne Lopes; Guilherme Macedo
Journal:  GE Port J Gastroenterol       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.